The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
Part of paid clinical trials in Springdale, Arkansas.
- Sponsor
- XP Technology, LLC
- Study ID
- NCT05055804
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- ELG — DEVICEThe effectiveness of ELG to standardized blood test methods (fingerstick) and comparison to AlcNOW + (or equivalence) and of laboratory test results. Human subject requirements during ELG study will not challenge diabetics or non-diabetics glycemic event. For example, diabetes type 1, the subject will not have to adjust their insulin or glucose. For type 2 diabetes, the subject will not have to adjust their oral hypoglycemic agent or glucose, as well.
Study Details
This study is an investigational study of the ELG medical device to monitor glucose blood level in diabetes mellitus Type 1 and 2 without blood samples in comparison to blood testing methods."Investigational" means the ELG medical device is subjected by the FDA (Food and Drug Administration) for premarket testing requirements. The purpose of this study is to collect data comparison values between ELG testing device to current blood testing methods.
Key Dates
- Start date
- Aug 11, 2021
- Status verified
- Jan 2025
- Primary completion
- Oct 31, 2025
- Completion
- Nov 30, 2025
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: ELG Device Comparison to Whole Blood TestingParticipant will place thumb in the ELG device for scan. Scan generally takes between 1-2 minutes. ELG then displays a readout of both a glucose and A1C reading on the screen of the ELG device.
Primary Outcome Measure
Standard OTC Glucose, A1C & Laboratory Results in Comparison to ELG Device During Fasting Event [ Time Frame: Visit will last for up to 1-2 hours. This outcome will measure overnight fasting results. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rouse Family Medical Clinic | Springdale | Arkansas | 72764 | - |
Find similar trials in Springdale, AR
By condition
By specialty
By research site
Related Studies
- Family Model DSME in FBOs in the RMIRecruiting · University of Arkansas · Springdale, Arkansas
- Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPHASE3 · Recruiting · vTv Therapeutics · Scottsdale, Arizona
- A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 DiabetesPHASE2 · Not Yet Recruiting · Novo Nordisk A/S · Little Rock, Arkansas
- TrialNet Pathway to Prevention of T1DRecruiting · University of South Florida · Orange, California